Precigen (PGEN) Land & Improvements (2013 - 2026)
Precigen (PGEN) reported Land & Improvements of $2.4 million for Q1 2026, up 1374.39% year-over-year from $164000.0 in Q1 2025, and little changed quarter-over-quarter from $2.4 million in Q4 2025.
Precigen (PGEN) Land & Improvements (2013 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Land & Improvements data on file, last reported at $2.4 million in Q1 2026.
- Land & Improvements for Q1 2026 came in at $2.4 million, up 1374.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (up 1374.39% YoY), and the FY2025 annual result was $2.4 million, up 1368.29% from the prior year.
- Land & Improvements held at $2.4 million in Q1 2026 per PGEN's latest filing, from $2.4 million in the prior quarter.
- Over five years, Land & Improvements peaked at $11.1 million in Q1 2022 and troughed at $164000.0 in Q2 2022.
- A 5-year average of $2.3 million and a median of $2.3 million in 2025 frame the typical range for Land & Improvements.
- On a YoY basis, Land & Improvements climbed as much as 2728.05% in 2023 and fell as far as 98.52% in 2023.
- A 5-year view of Land & Improvements shows it stood at $4.6 million in 2022, then tumbled by 96.41% to $164000.0 in 2023, then changed by 0.0% to $164000.0 in 2024, then jumped by 1368.29% to $2.4 million in 2025, then climbed by 0.42% to $2.4 million in 2026.
- Business Quant data shows PGEN's Land & Improvements at $2.4 million in Q1 2026, $2.4 million in Q4 2025, and $2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Precigen | 1.32 Bn | 1.32 Bn | 20.69 Mn | 2.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.42 Mn |
| Dec 31, 2025 | 2.41 Mn |
| Sep 30, 2025 | 2.90 Mn |
| Jun 30, 2025 | 2.28 Mn |
| Mar 31, 2025 | 164,000.00 |
| Dec 31, 2024 | 164,000.00 |
| Sep 30, 2024 | 164,000.00 |
| Jun 30, 2024 | 164,000.00 |
| Mar 31, 2024 | 3.48 Mn |
| Dec 31, 2023 | 164,000.00 |
| Sep 30, 2023 | 3.68 Mn |
| Jun 30, 2023 | 4.64 Mn |
| Mar 31, 2023 | 164,000.00 |
| Dec 31, 2022 | 4.56 Mn |
| Sep 30, 2022 | 164,000.00 |
| Jun 30, 2022 | 164,000.00 |
| Mar 31, 2022 | 11.12 Mn |
| Dec 31, 2021 | 4.82 Mn |
| Sep 30, 2021 | 5.43 Mn |
| Jun 30, 2021 | 5.75 Mn |